Qualigen Therapeutics Inc (QLGN)

Jan 17, 2025

Microbiomes Market to Grow by USD 1.13 Billion (2024-2028), Driven by Rising Disease Prevalence; AI Impact on Market TrendsTechnavio - The Malaysian Reserve

Jan 17, 2025

Jan 10, 2025

Qualigen Therapeutics (NASDAQ:QLGN) Stock Price Down 5.2% – Time to Sell? - Defense World

Jan 10, 2025

Jan 10, 2025

Qualigen Therapeutics (NASDAQ:QLGN) Shares Down 5.2% – Here’s Why - Defense World

Jan 10, 2025

Dec 19, 2024

Qualigen Therapeutics (NASDAQ:QLGN) Trading Down 7.8% – Time to Sell? - Defense World

Dec 19, 2024

Dec 10, 2024

SEC Form S-1 filed by Qualigen Therapeutics Inc. - Quantisnow

Dec 10, 2024

Dec 06, 2024

Qualigen Therapeutics regains compliance with Nasdaq's listing requirements - MSN

Dec 06, 2024

Dec 05, 2024

Qualigen Therapeutics regains Nasdaq compliance By Investing.com - Investing.com UK

Dec 05, 2024

Dec 05, 2024

Qualigen Therapeutics Announces Regained Compliance with - GlobeNewswire

Dec 05, 2024

Dec 05, 2024

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement - Yahoo Finance

Dec 05, 2024

Nov 25, 2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - The Manila Times

Nov 25, 2024

Nov 25, 2024

Univest Securities, LLC Announces Successful Closing of - GlobeNewswire

Nov 25, 2024

Nov 22, 2024

Qualigen Therapeutics, Inc. announced that it expects to receive $5.1 million in funding - Marketscreener.com

Nov 22, 2024

Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding By Investing.com - Investing.com South Africa

Nov 19, 2024

Nov 19, 2024

Qualigen Therapeutics secures $4.5 million in funding - Investing.com India

Nov 19, 2024

Nov 19, 2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - The Manila Times

Nov 19, 2024

Nov 18, 2024

Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World

Nov 18, 2024

Nov 15, 2024

Qualigen Therapeutics Inc (QLGN) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

Qualigen Therapeutics appoints new board member - Investing.com

Nov 14, 2024

Nov 14, 2024

Qualigen Therapeutics appoints new board member By Investing.com - Investing.com Canada

Nov 14, 2024

Nov 13, 2024

QLGN Stock Touches 52-Week Low at $3.71 Amid Market Challenges - Investing.com Canada

Nov 13, 2024

Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split - Investing.com India

Nov 11, 2024

Nov 11, 2024

Qualigen Therapeutics announces 1-for-50 reverse stock split By Investing.com - Investing.com UK

Nov 11, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Enterprise Value : €4.58 Mil (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Operating Cash Flow per Sh - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Shares Outstanding (EOP) : 0.19 Mil (As of Jun. 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Long-Term Debt & Capital L - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) EV-to-Revenue : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Qualigen Therapeutics (STU:7R90) Cash Flow from Financing : €1.51 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 07, 2024

Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Nov 06, 2024

Nov 06, 2024

Qualigen Therapeutics, Inc. Announces Appointment of Amy Broidrick as Executive Vice President and Chief Strategy Officer - Marketscreener.com

Nov 06, 2024

Nov 05, 2024

QLGN stock touches 52-week high at $5.05 amid market fluctuations - Investing.com

Nov 05, 2024

Nov 03, 2024

Qualigen Therapeutics Stock to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN) - Defense World

Nov 03, 2024

Nov 01, 2024

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewswire

Nov 01, 2024

Oct 30, 2024

Would I Buy Qualigen Therapeutics Inc (NASDAQ: QLGN) Stock At Any Time In The Future? - Stocks Register

Oct 30, 2024

Oct 30, 2024

Qualigen Therapeutics announces results of annual stockholder meeting By Investing.com - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

Qualigen Therapeutics announces results of annual stockholder meeting - Investing.com India

Oct 29, 2024

Oct 26, 2024

Qualigen Therapeutics (STU:7R9) Enterprise Value : €4.47 Mil (As of Oct. 26, 2024) - GuruFocus.com

Oct 26, 2024

Oct 25, 2024

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - openPR

Oct 25, 2024

Oct 25, 2024

QLGN stock touches 52-week low at $0.11 amid market challenges - Investing.com India

Oct 25, 2024

Oct 23, 2024

Qualigen Therapeutics faces Nasdaq delisting notice By Investing.com - Investing.com Canada

Oct 23, 2024

Oct 22, 2024

Qualigen Therapeutics faces Nasdaq delisting notice - Investing.com India

Oct 22, 2024

Oct 19, 2024

Qualigen Therapeutics (NASDAQ:QLGN) Shares Up 4.4% – Here’s Why - Defense World

Oct 19, 2024

Oct 09, 2024

Qualigen Therapeutics appoints new director and audit chair By Investing.com - Investing.com South Africa

Oct 09, 2024

Oct 09, 2024

Qualigen Therapeutics appoints new director and audit chair - Investing.com India

Oct 09, 2024